Press Releases
Filter By Year
2022
January
-
January 25, 2022
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine -
January 21, 2022
FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression -
January 18, 2022
Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022 -
January 10, 2022
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer
Filter By Year